BOCA RATON, Fla., Aug. 27, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), today announced that Joe Sardano, President and Chief Executive Officer, will participate at two investor conferences in September 2018, as follows:
|
Annual B. Riley FBR Healthcare Conference |
|
|
Date: |
Tuesday, September 4, 2018 |
|
Format: |
One-on-one meetings only |
|
Venue: |
New York Marriott East Side in New York City |
|
H.C. Wainwright 20th Annual Global Investment Conference |
|
|
Date: |
September 4-6, 2018 |
|
Format: |
Company presentation |
|
Presentation: |
Thursday, September 6, 2018 at 11:40 a.m. Eastern time |
|
Venue: |
St. Regis New York Hotel in New York City |
Mr. Sardano’s presentation at the H.C. Wainwright 20th Annual Global Investment Conference will be webcast live and available for replay in the Investor Relations section of the Company’s website at sensushealthcare.com.
About Sensus Healthcare
Sensus Healthcare, Inc. is a medical device company that is committed to providing non-invasive and cost-effective treatment for non-melanoma skin cancers and keloids. Sensus uses a proprietary low energy X-ray technology known as superficial radiation therapy (SRT), which is a result of over a decade of dedicated research and development. Sensus has successfully incorporated SRT therapy into its portfolio of treatment devices, the SRT-100™ and SRT-100 Vision™. To date, SRT technology has been used to effectively and safely treat oncological and non-oncological skin conditions in thousands of patients. For more information, visit https://sensus.ericchesbrough.com.
Contact:
LHA Investor Relations
Kim Sutton Golodetz
(212) 838-3777
kgolodetz@lhai.com
View original content:https://www.prnewswire.com/news-releases/sensus-healthcare-to-participate-in-two-upcoming-investor-conferences-300702054.html
SOURCE Sensus Healthcare